Days before starting work on the Opioids Conference Committee on Wednesday, U.S. Representative Patrick Meehan took the time to visit Radnor’s manufacturer of Narcan, the nasal spray that revives people overdosing on opioids, writes Kathleen E. Carey for Daily Local News.

While naloxone has been in use for over four decades, Adapt Pharma, founded only three years ago, was the first to develop a solid unit nasal spray to help administer the naloxone on the spot.

“It was expedited and approved by the FDA within four months,” said Mike Kelly. Adapt’s President of U.S. operations.

The first customer for the new nasal spray was Delaware County and it is now used by numerous police departments in the area who administer the drug when someone is overdosing on opioids.

“All you have to do is stick in someone’s nose and then there’s one press and that’s it,” said Thom Duddy, Adapt’s Executive Director of Marketing and Communications. “It’s a mist so it attaches onto the nasal mucosa, goes into the bloodstream rapidly and it goes into the frontal cortex and wipes off the opioid on the receptors to the brain.”

After the company tour, Meehan expressed his thanks for the visit.

“I appreciated that they were here in the backyard,” he said. “I wanted to make sure that I got here in a timely basis before we went down and did the conference committee on the opioid bill.”

Read more about the visit at Daily Local News here, and check out previous VISTA Today coverage of Adapt Pharma here.